Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01611454 · ClinicalTrials.gov registry record · NA
New Fabric Attenuation Device in Endovascular Interventional Radiology II (PREFER II)
A NA study, sponsored by Baptist Health South Florida.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01611454 is a NA study that has completed, run by Baptist Health South Florida. The registered enrollment target is 106 participants.
The verdict
NCT01611454, a NA study, has completed, sponsored by Baptist Health South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
The PREFER II trial primary objective of the trial is to show how much radiation attenuation is provided by XPF thyroid collars in absolute and relative terms.
Interventions
- DEVICE XPF thyroid collar
- DEVICE Standard 0.5mm lead equivalent thyroid collar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01611454
The ClinicalTrials.gov registry entry for NCT01611454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which XPF thyroid collar is the first listed.
NCT01611454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01611454 about?
NCT01611454 is a clinical study titled "New Fabric Attenuation Device in Endovascular Interventional Radiology II (PREFER II)". The PREFER II trial primary objective of the trial is to show how much radiation attenuation is provided by XPF thyroid collars in absolute and relative terms.
What is the current status of trial NCT01611454?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2011-05. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01611454?
The interventions under investigation include: XPF thyroid collar (DEVICE), Standard 0.5mm lead equivalent thyroid collar (DEVICE).
Who is sponsoring clinical trial NCT01611454?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.